189 related articles for article (PubMed ID: 22746324)
1. Synthesis and evaluation of substituted chroman-4-one and chromone derivatives as sirtuin 2-selective inhibitors.
Fridén-Saxin M; Seifert T; Landergren MR; Suuronen T; Lahtela-Kakkonen M; Jarho EM; Luthman K
J Med Chem; 2012 Aug; 55(16):7104-13. PubMed ID: 22746324
[TBL] [Abstract][Full Text] [Related]
2. Chroman-4-one- and chromone-based sirtuin 2 inhibitors with antiproliferative properties in cancer cells.
Seifert T; Malo M; Kokkola T; Engen K; Fridén-Saxin M; Wallén EA; Lahtela-Kakkonen M; Jarho EM; Luthman K
J Med Chem; 2014 Dec; 57(23):9870-88. PubMed ID: 25383691
[TBL] [Abstract][Full Text] [Related]
3. A scaffold replacement approach towards new sirtuin 2 inhibitors.
Seifert T; Malo M; Kokkola T; Stéen EJL; Meinander K; Wallén EAA; Jarho EM; Luthman K
Bioorg Med Chem; 2020 Jan; 28(2):115231. PubMed ID: 31848116
[TBL] [Abstract][Full Text] [Related]
4. Identification of the Binding Site of Chroman-4-one-Based Sirtuin 2-Selective Inhibitors using Photoaffinity Labeling in Combination with Tandem Mass Spectrometry.
Seifert T; Malo M; Lengqvist J; Sihlbom C; Jarho EM; Luthman K
J Med Chem; 2016 Dec; 59(23):10794-10799. PubMed ID: 27933951
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors.
Suzuki T; Khan MN; Sawada H; Imai E; Itoh Y; Yamatsuta K; Tokuda N; Takeuchi J; Seko T; Nakagawa H; Miyata N
J Med Chem; 2012 Jun; 55(12):5760-73. PubMed ID: 22642300
[TBL] [Abstract][Full Text] [Related]
6. Conjugate addition of isocyanides to chromone 3-carboxylic acid: an efficient one-pot synthesis of chroman-4-one 2-carboxamides.
Neo AG; Díaz J; Marcaccini S; Marcos CF
Org Biomol Chem; 2012 May; 10(17):3406-16. PubMed ID: 22434156
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton.
Sakai T; Matsumoto Y; Ishikawa M; Sugita K; Hashimoto Y; Wakai N; Kitao A; Morishita E; Toyoshima C; Hayashi T; Akiyama T
Bioorg Med Chem; 2015 Jan; 23(2):328-39. PubMed ID: 25515955
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Evaluation of Novel Benzofuran Derivatives as Selective SIRT2 Inhibitors.
Zhou Y; Cui H; Yu X; Peng T; Wang G; Wen X; Sun Y; Liu S; Zhang S; Hu L; Wang L
Molecules; 2017 Aug; 22(8):. PubMed ID: 28805748
[TBL] [Abstract][Full Text] [Related]
9. Discovery of (5-Phenylfuran-2-yl)methanamine Derivatives as New Human Sirtuin 2 Inhibitors.
Wang L; Li C; Chen W; Song C; Zhang X; Yang F; Wang C; Zhang Y; Qian S; Wang Z; Yang L
Molecules; 2019 Jul; 24(15):. PubMed ID: 31357491
[TBL] [Abstract][Full Text] [Related]
10. Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors.
Gaspar A; Silva T; Yáñez M; Vina D; Orallo F; Ortuso F; Uriarte E; Alcaro S; Borges F
J Med Chem; 2011 Jul; 54(14):5165-73. PubMed ID: 21696156
[TBL] [Abstract][Full Text] [Related]
11. Identification of Diketopiperazine-Containing 2-Anilinobenzamides as Potent Sirtuin 2 (SIRT2)-Selective Inhibitors Targeting the "Selectivity Pocket", Substrate-Binding Site, and NAD
Mellini P; Itoh Y; Elboray EE; Tsumoto H; Li Y; Suzuki M; Takahashi Y; Tojo T; Kurohara T; Miyake Y; Miura Y; Kitao Y; Kotoku M; Iida T; Suzuki T
J Med Chem; 2019 Jun; 62(12):5844-5862. PubMed ID: 31144814
[TBL] [Abstract][Full Text] [Related]
12. Discovery of 2-((4,6-dimethylpyrimidin-2-yl)thio)-N-phenylacetamide derivatives as new potent and selective human sirtuin 2 inhibitors.
Yang L; Ma X; Yuan C; He Y; Li L; Fang S; Xia W; He T; Qian S; Xu Z; Li G; Wang Z
Eur J Med Chem; 2017 Jul; 134():230-241. PubMed ID: 28415012
[TBL] [Abstract][Full Text] [Related]
13. 3-(N-arylsulfamoyl)benzamides, inhibitors of human sirtuin type 2 (SIRT2).
Choi SH; Quinti L; Kazantsev AG; Silverman RB
Bioorg Med Chem Lett; 2012 Apr; 22(8):2789-93. PubMed ID: 22446090
[TBL] [Abstract][Full Text] [Related]
14. Structure-based design of pseudopeptidic inhibitors for SIRT1 and SIRT2.
Huhtiniemi T; Salo HS; Suuronen T; Poso A; Salminen A; Leppänen J; Jarho E; Lahtela-Kakkonen M
J Med Chem; 2011 Oct; 54(19):6456-68. PubMed ID: 21895016
[TBL] [Abstract][Full Text] [Related]
15. Hit evaluation results in 5-benzyl-1,3,4-thiadiazole-2-carboxamide based SIRT2-selective inhibitor with improved affinity and selectivity.
Gozelle M; Kaya SG; Aksel AB; Ozkan E; Bakar-Ates F; Ozkan Y; Eren G
Bioorg Chem; 2022 Jun; 123():105746. PubMed ID: 35358824
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, in-vitro evaluation and molecular docking studies of novel indole derivatives as inhibitors of SIRT1 and SIRT2.
Manjula R; Gokhale N; Unni S; Deshmukh P; Reddyrajula R; Srinivas Bharath MM; Dalimba U; Padmanabhan B
Bioorg Chem; 2019 Nov; 92():103281. PubMed ID: 31561106
[TBL] [Abstract][Full Text] [Related]
17. Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors.
Legoabe LJ; Petzer A; Petzer JP
Bioorg Chem; 2012 Dec; 45():1-11. PubMed ID: 23064123
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 2-alkyl-chroman-4-ones via cascade alkylation-dechlorination of 3-chlorochromones.
Li S; Zhang L; He Q; Zhang X; Yang C
Org Biomol Chem; 2021 Jun; 19(24):5348-5352. PubMed ID: 34042936
[TBL] [Abstract][Full Text] [Related]
19. Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3.
Disch JS; Evindar G; Chiu CH; Blum CA; Dai H; Jin L; Schuman E; Lind KE; Belyanskaya SL; Deng J; Coppo F; Aquilani L; Graybill TL; Cuozzo JW; Lavu S; Mao C; Vlasuk GP; Perni RB
J Med Chem; 2013 May; 56(9):3666-79. PubMed ID: 23570514
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of certain benzothieno[3,2-d]pyrimidine derivatives as a selective SIRT2 inhibitors.
Khalil NA; Ahmed EM; Zaher AF; El-Zoghbi MS; Sobh EA
Eur J Med Chem; 2020 Feb; 187():111926. PubMed ID: 31812033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
